Credit Suisse Upgrades Medtronic (MDT) to Outperform
MDT Hot Sheet
Rating Summary:8 Buy, 17 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 9 | New: 26
Credit Suisse upgrades Medtronic, Inc. (NYSE: MDT) from Neutral to Outperform.
Medtronic, Inc. develops, manufactures, and sells device-based medical therapies worldwide.
Medtronic, Inc. develops, manufactures, and sells device-based medical therapies worldwide.
You May Also Be Interested In
- QUAN Contacts New Robotics Targets
- Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
- Pre-Open Movers 5/22: (EDGR) (BNHN) (RL) Higher; (EXPR) (FB0 (AZO) Lower (more...)
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
